Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1-Reference-Cited by-同舟云学术

Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1

Published:2024-03-11 Issue:3 Volume:37 Page:874-885
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Adachi Yuki^ORCID,Noguchi Rei^ORCID,Yoshimatsu Yuki^ORCID,Sin Yooksil,Osaki Julia^ORCID,Ono Takuya^ORCID,Iwata Shuhei^ORCID,Akiyama Taro^ORCID,Tsuchiya Ryuto^ORCID,Toda Yu,Ishihara Shin^ORCID,Ogura Koichi,Kobayashi Eisuke^ORCID,Kojima Naoki^ORCID,Yoshida Akihiko,Yokoo Hideki^ORCID,Kawai Akira^ORCID,Kondo Tadashi^ORCID

Funder

the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13577-024-01042-5.pdf

Reference35 articles.

1. board WHOcte. Soft tissue and bone tumours. 5th ed. World Health Organization classification of tumours. World Health Organization. International Agency for Research on Cancer; 2020.

2. Nagano A, Urakawa H, Tanaka K, Ozaki T. Current management of giant-cell tumor of bone in the denosumab era. Jpn J Clin Oncol. 2022;52(5):411–6. https://doi.org/10.1093/jjco/hyac018.

3. Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am. 2006;37(1):35–51. https://doi.org/10.1016/j.ocl.2005.08.005.

4. Rekhi B, Dave V. Giant cell tumor of bone: an update, including spectrum of pathological features, pathogenesis, molecular profile and the differential diagnoses. Histol Histopathol. 2023;38(2):139–53. https://doi.org/10.14670/hh-18-486.

5. Basu Mallick A, Chawla SP. Giant cell tumor of bone: an update. Curr Oncol Rep. 2021;23(5):51. https://doi.org/10.1007/s11912-021-01047-5.